BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

Velafermin rhFGF-20 Pages on BioPortfolio:

BioPortfolio - Velafermin rhFGF-20
Velafermin rhFGF-20 - BioPortfolio. ... Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated
...
http://www.bioportfolio.com/search/Velafermin__rhFGF-20__.ht...

BioPortfolio - CuraGen
Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation. PURPOSE: Velafermin (recombinant
...
http://www.bioportfolio.com/biocorporate/3125-CuraGen.html...

BioPortfolio - curagen oral mucositis
BioPortfolio - curagen oral mucositis BioPortfolio - CuraGen Velafermin (rhFGF- 20) reduces the severity and duration of hamster cheek pouch mucositis . ...
http://www.bioportfolio.com/search/curagen_oral_mucositis.ht...

Results from other life science and pharmaceutical sites:

Velafermin (rhFGF-20) reduces the severity and duration of hamster ...
PURPOSE: Velafermin (recombinant human fibroblast growth factor-20, rhFGF-20) has been shown to reduce the severity and duration of mucositis in preclinical
...
http://www.ncbi.nlm.nih.gov/pubmed/18464069...

BioPortfolio - CuraGen
Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation. PURPOSE: Velafermin (recombinant
...
http://www.bioportfolio.com/biocorporate/3125-CuraGen.html...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.